Latest News

Partial immunization leaves children and communities at risk, study finds


 

TOPLINE

A new American Academy of Pediatrics study reveals that 17.2% of toddlers started but did not finish at least one recommended early childhood vaccine series.

METHODOLOGY

  • Examined data collected in 2019 from the National Immunization Survey – Child.
  • 16,365 children ages 19-35 months were included.
  • Vaccines for diphtheria, tetanus, acellular pertussis, pneumococcal infections, Haemophilus influenzae type b, hepatitis B, polio, measles, mumps, rubella, and varicella were included.

TAKEAWAY

  • 72.9% of toddlers completed the seven-vaccine series.
  • 17.2% initiated but did not complete one or more of a multidose vaccine series.
  • The strongest association with not completing the vaccine series was moving across state lines and not having insurance.
  • Children with more siblings at home were less likely to complete a vaccine series.

IN PRACTICE

The study suggests that the “children experienced structural barriers to vaccination,” and the authors urge an “increased focus on strategies to encourage multidose series completion ... to optimize protection from preventable diseases and achieve vaccination coverage goals.”

SOURCE

The study was funded by the National Institutes of Health and published online July 25 in Pediatrics. Sarah Y. Michels, an epidemiology specialist from the University of Montana in Missoula, was the lead author.

LIMITATIONS

Though the researchers studied the risk factors for series noncompletion, they did not have information on the specific reasons why children were missing vaccine doses. Children whose parents chose to participate in the National Immunization Survey – Child may have had higher vaccination coverage than children whose parents declined participation.

DISCLOSURES

The authors have reported no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Recommended Reading

Safety remains top parent concern for HPV vaccine
Federal Practitioner
The new vaccine your patients may not want
Federal Practitioner
COVID vaccines safe for young children, study finds
Federal Practitioner
Latest data: COVID vaccine safety, protection, and breakthrough infections in inflammatory, autoimmune diseases
Federal Practitioner
FDA panel backs new COVID booster focusing only on variants
Federal Practitioner
HPV rates skyrocket despite safe, effective vaccine
Federal Practitioner
Long COVID and vaccines: Separating facts from falsehoods
Federal Practitioner
Pneumococcal vaccine label adds injection-site risk
Federal Practitioner
Screening for hepatitis B: Where the CDC and USPSTF diverge
Federal Practitioner
CDC offers guidance on RSV vaccines for adults
Federal Practitioner